SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Conflicting analyst views are driving attention: Edgewater warned that AppLovins market-share growth may be stalling and competition could pressure ad margins, while Citi highlighted faster e-commerce client growth. Traders are debating whether the pullback reflects real growth and competition concerns or presents a buying opportunity, amid volatile price action.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Supermicros reported first shipments of NVIDIA Vera Rubin rack-scale systems to SpaceXAI are fueling discussion of its AI-server opportunity, alongside optimism about expanding AI infrastructure demand and customer partnerships. Bulls see the recent strength as a possible breakout and cite short interest, while skeptics point to repeated resistance, dilution, and concerns about margins and management credibility.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos capital-markets strategy and growth outlook have drawn scrutiny, with traders focused on mid-term growth expectations, intensifying Eli Lilly competition, and semaglutides future patent cliff; many say the plans failed to restore confidence and criticize management. Others argue the selloff overstates the risks, pointing to the companys valuation, pipeline, and Wegovy-pill demand.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs demonstration of a real-time quantum error-correction decoder running on a standard CPU is driving attention, with traders viewing it as progress toward fault-tolerant quantum computing. Bulls call it a meaningful technical milestone, while skeptics note the results were based on simulations rather than a deployed large-scale quantum system and question whether the rally will hold.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduros progress toward commercializing its Hydrochemolytic Technologyparticularly continuous-flow testing of paraffinic crude and advancing the ECOCE plastics collaboration to HCT trialsis driving attention. Bulls see these developments and FOAK-plant work as validation, while skeptics question whether the process can scale economically and warn of dilution before revenue.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds investor-day strategy update, including plans to invest in restaurant upgrades and training, has drawn attention as the company sets out its growth priorities. Traders are split on whether the plan can revive weak U.S. traffic and address affordability concerns: some see an opportunity in the beaten-down shares, while others doubt the strategy will reverse the decline.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros steep slide from its recent highs and repeated 52-week lows are driving discussion, with traders debating whether valuation compression and concerns about consumer spending and competition justify more downside. Some see the selloff as an oversold buying opportunity, while others argue the stock remains expensive and expect further declines.

GEOM maps the world's oil fields, mines, rare earths, and power plants, tracks what is and isn't tokenized, and cryptographically signs every dataset it publishes. Anyone can verify what we said and when. No account, no key, no permission. Sources include the WRI Global Power Plant Database and Global Energy Monitor (CC BY 4.0), attributed in full inside the app. Most of it already exists, spread across filings and terminals no one reads. GEOM gathers it and records where each figure came from.

GEOM

GEOMs rally is drawing attention as traders focus on its proposed platform for tokenizing oil and mineral assets and royalties, often linking the project to Greenland-related companies and anticipated platform developments. The discussion is heavily bullish on the tokens potential, but some traders warn of thin liquidity, sharp swings, and scam or further-decline risk; the proposed catalysts remain speculative.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp rally has traders speculating that ImmunityBio founder Patrick Soon-Shiongs meeting with Turkeys president could lead to an Anktiva approval or expansion, though no Turkish deal is confirmed. Chatter about possible Nant tokenized stock trading is also fueling short-squeeze theories, while skeptics point out that no company announcement has explained the move.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers proposed convertible senior notes offering is driving the conversation, with traders concerned about potential dilution, financing needs, and near-term selling pressure. Others view the reaction as an opportunity, arguing the notes are not immediately dilutive and maintaining a bullish long-term view of the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XWEL very happy for the long here! 

I wish I could’ve bought the 4$ dip today and Friday. I had not settled funds but knew it was a ticking time bomb after I researched this company over the weekend. Praying ktov makes similar moves tomorrow off PR and I can move profits into xspa after whatever dips may happen before next weeks likely lga focused Pr

Big Horn

Biotech Warren Buffett

Bobby

StockTwits for iOS

XpresSpa Group Inc

$XSPA very happy for the long here! 

I wish I could’ve bought the 4$ dip today and Friday. I had not settled funds but knew it was a ticking time bomb after I researched this company over the weekend. Praying ktov makes similar moves tomorrow off PR and I can move profits into xspa after whatever dips may happen before next weeks likely lga focused Pr

@Dlord bro still time to get in...just getting started. Be great to hear your discourse over here...

 bro still time to get in...just getting started. Be great to hear your discourse over here...

@Deathmetaldarrel oh I will 100%. I love this stocks potential. Management delivering today has me stoked. But I’m a greedy sob so I’m aiming to get in on ER sentiment dip before LaGuardia news next week. I’m thinking this May dip on vaccine news this week too, but either way I’ll load up by eow. I expect 20-40$ if pilot scales and they go to multiple airports with contracts supported by end of summer. If they can pull it off on cruise ships then fucking to the moon

 oh I will 100%. I love this stocks potential. Management delivering today has me stoked. But I’m a greedy sob so I’m aiming to get in on ER sentiment dip before LaGuardia news next week. I’m thinking this May dip on vaccine news this week too, but either way I’ll load up by eow. I expect 20-40$ if pilot scales and they go to multiple airports with contracts supported by end of summer. If they can pull it off on cruise ships then fucking to the moon

@Dlord exactly my thoughts...I got in at .44 back in the day and then avg’d up some, went through the RS and now sit at 1.73...stoked on the potential. Thanks for your response bro. 

Was just looking for some of your old DD on PTI actually...have a good bro who wants to jump in and I’m having hard times articulating it like you do...I’m just like buy the fkn thing already and go long!!

 exactly my thoughts...I got in at .44 back in the day and then avg’d up some, went through the RS and now sit at 1.73...stoked on the potential. Thanks for your response bro. 

Was just looking for some of your old DD on PTI actually...have a good bro who wants to jump in and I’m having hard times articulating it like you do...I’m just like buy the fkn thing already and go long!!

@Deathmetaldarrel I need to update it, a good amount of things have changed though core buying thesis hasn&#39;t really, you can find it on reddit though https://www.reddit.com/r/Biotechplays/comments/eldsvx/pti_super_bull_thesis_my_top_20202021_pick_part_3/ outdated view though it is useful for some things

Justin

reddit

PTI Super Bull Thesis, my top 2020/2021 pick (Part 3 of PTI DD)

StockTwits Web

 I need to update it, a good amount of things have changed though core buying thesis hasn't really, you can find it on reddit though 

 outdated view though it is useful for some things

@Dlord Thanks a lot brotha! Exactly what I needed...looking forward to seeing you on the xspa board. Saw you in Ktov too

 Thanks a lot brotha! Exactly what I needed...looking forward to seeing you on the xspa board. Saw you in Ktov too

@Dlord I remember you from vbiv, good to see you here. The volatility here is pretty exciting that’s for sure

 I remember you from vbiv, good to see you here. The volatility here is pretty exciting that’s for sure

@Dang_it_Bobby good seeing you man,  yeah I&#39;m pumped for xspa if CEO can pull it off, i love the narrative here as much as the money making multi-bagger potential!

 good seeing you man,  yeah I'm pumped for xspa if CEO can pull it off, i love the narrative here as much as the money making multi-bagger potential!

@Dlord yeah safe to say we are still a bit early in here with lots of potential following additional contracts. It would be financial suicide to close down again and seems like testing employees is in the right direction to reopening

 yeah safe to say we are still a bit early in here with lots of potential following additional contracts. It would be financial suicide to close down again and seems like testing employees is in the right direction to reopening